Z-Val-Lys-Met-AMC acetate salt
CAS: 141223-71-4
Ref. 3D-FV110562
10mg | 343,00 € | ||
25mg | 572,00 € | ||
50mg | 948,00 € | ||
100mg | 1.552,00 € | ||
250mg | 3.374,00 € |
Informação sobre produto
- Z-Val-Lys-Met-AMC
Bortezomib is a proteasome inhibitor that binds to the catalytic site of the proteasome and inhibits its activity. Bortezomib is used as an anticancer agent to treat multiple myeloma, T-cell lymphomas, and other cancers. It has been shown to inhibit the growth of cancer cells and slow tumor progression in animal models. The drug has also been shown to decrease insulin resistance in mice with high blood sugar levels by inhibiting histone deacetylase (HDAC). This inhibition leads to increased expression of genes that are involved in glucose metabolism and decreased expression of genes that regulate fat production.
The drug also binds tightly to the insulin receptor, which may lead to improved glucose uptake into cells.
Propriedades químicas
Consulta técnica sobre: 3D-FV110562 Z-Val-Lys-Met-AMC acetate salt
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.